Saily Medical disclosed its earnings forecast, expecting a net loss attributable to shareholders of 35 million to 50 million yuan in the first half of 2026, compared with a loss of 56.1192 million yuan in the same period last year. The net loss after deducting non-recurring items is expected to be 36 million to 51 million yuan, compared with a loss of 70.5979 million yuan a year earlier. The company said the change in performance was mainly due to the strategic transformation from traditional medical supply chain services to intelligent medical services, coupled with the implementation of industry reform policies and increased regulatory oversight, which led to a decline in revenue for some projects due to business transformation. Based on the latest closing price, the company's price-to-book ratio is about 3.16 times, and its price-to-sales ratio is about 3.28 times.
Wuhan Thalys Med Tech Co LtdCompany expects a net loss of 35-50 million yuan in H1 2026, though narrowed from prior year.